Healthcare | August 22, 2025
Fortis Healthcare signs O&M agreement with Ekana Group for 550-bed hospital in Lucknow
The facility will be positioned as a Centre of Excellence for tertiary care services
The facility will be positioned as a Centre of Excellence for tertiary care services
Vivo Bio Tech will have end-to-end responsibility for conducting the full spectrum of pre-clinical safety and regulatory studies
This acquisition expands HGM's healthcare platform capabilities in revenue cycle management
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
The patient had been battling DFSP for over eight years, enduring multiple recurrences despite three previous surgeries
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
According to IQVIA sales data for the 12-month period ending June 2025, the Mycamine for Injection, 50 mg/vial and 100 mg/vial market achieved annual sales of approximately $60.7 million
Sarepta has also entered into an agreement with Arrowhead to transfer 2,660,989 shares of Arrowhead common stock in satisfaction of $50 million of the company’s previously announced $100 million milestone payment obligation
The randomized, double-blind, placebo-controlled Phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102 in healthy participants
Subscribe To Our Newsletter & Stay Updated
